A new study published in The Lancet Journal states that a three-month interval between two doses of the Oxford vaccine is more effective. The study compared it to a gap of six weeks. With this, it has been claimed to get 76 percent protection from single dose of vaccine.
New Delhi: Vaccination is being done to beat Corona in many countries of the world. Meanwhile, a new study has revealed that a three-month gap between two doses of the Oxford Kovid-19 vaccine is more effective than a six-week gap. According to the study, the first dose gives 76 percent protection.
According to the analysis of the results of a trial published in The Lancet Journal, the time between doses can be safely extended to three months. According to researchers at the University of Oxford in the UK, this dose of Dose is beneficial when vaccine supply is still limited. In such a situation, many countries can get a large portion of the population vaccinated fast.
Single dose will accelerate vaccination
Professor Andrew Pollard of the University of Oxford, who led the study, said, “The supply of vaccines has to be limited. Policy-makers have to decide which method can be the best for dosing people in the shortest possible time.” is.”
Pollard believes that the policy of initially vaccinating more people with a single dose is better than vaccinating half the people with two doses. Especially in places where the supply of the Oxford vaccine is limited. According to him, long-term immunity is ensured in the second dose and hence people taking the first dose are encouraged to take the second dose.
Analysis of data of 17,178 people
These included the risk of infection between dose intervals, low efficacy of one dose and efficacy at the other time. He combined clinical trial data in the UK, Brazil and South Africa, which included a total of 17,178 adult participants.
76% protection from single dose
According to scientists, people who were given doses in 12 or more weeks got more protection than those who got 2 doses in less than six weeks. Researchers said that the vaccine efficacy was 76 percent among those included in the study from 22 days to three months after taking a single dose.
Nidhi Malviya is fun loving girl. She writes at NoobFeeds about various topics related to Finance, Technology, Business etc.